↓ Skip to main content

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
Published in
Journal for Immunotherapy of Cancer, November 2014
DOI 10.1186/2051-1426-2-s3-p80
Authors

Chihiro Morishima, Douglas G McNeel, Manish R Patel, Holbrook Kohrt, Thomas A Waldmann, John A Thompson, Kevin Conlon, Paul M Sondel, Heather Wakelee, Mary L Disis, Stephen P Creekmore, Jeffrey S Miller

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 100%
Readers by discipline Count As %
Medicine and Dentistry 2 100%